News & Blogs - Cognes

Skip to content

Home
Solution
News & Blogs

Menu

Home
Solution
News & Blogs

Contact us

Latest News

Cognes Medical Solutions Selected Among Top 100 Innovators Advancing to the Entrepreneurship World Cup Global Finals

Cognes Medical Solutions Selected Among Top 100 Innovators Advancing to the Entrepreneurship World Cup Global Finals Cognes Medical Solutions is

Cognes to Entrepreneurship World Cup Top 250

Cognes Medical Solutions Advances to Next Phase of the Entrepreneurship World Cup
Company will compete for a trip to the Global Finals and a share of $US1M in cash prizes

Alzheimer’s Treatment Assessment: Innovative Strategies for Optimal Results

Alzheimer’s disease, a formidable adversary in the realm of neurodegenerative diseases, affects millions worldwide, presenting a significant challenge to both

Non-Invasive Dementia Care Technology by Cognes Medical Solutions Granted European Patent

On March 20, 2024, the European Patent Office (EPO) officially granted Cognes Medical Solutions AB a patent for its novel

Mild Cognitive Impairment (MCI): A Complex Form of Dementia

Lingering concerns about your memory? Discover the subtle signs and underlying causes of Mild Cognitive Impairment in this insightful guide.

pills, medicine, prescription-3673645.jpg

Which Medicines Treat Dementia the Best?

Step into the world of dementia treatment with a deep dive into the effectiveness of various medications – the key to unlocking better care for those affected.

For investigational purposes only. The Cognes Solution has not yet been evaluated for clinical safety or effectivness. The Cognes Solution is currently not available for sale.

Main Menu

Home
Solution
News & Blogs

Home
Solution
News & Blogs

Get In Touch

Cognes Medical Solutions AB, KIVRA: 559267-5580, 106 31 Stockholm, SWEDEN

Email: hello@cognes.co

Follow our journey

Sign up for our newsletter to keep up with our journey:

Email

Scroll to Top